000			01276nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aMicroRNA in Solid Tumor and Hematological Diseases
546			_aEnglish[eng]
650			_abladder cancer||urine||miRNA||reference miRNA||normalizer||RT-qPCR||miR-139-5p||miR-139-3p||renal cell carcinoma (RCC)||microRNA||tumor suppressor||paxillin (PXN)||acute myeloblastic leukemia||acute lymphoblastic leukemia||colorectal cancer||amino acid transporters||LAT1||ASCT2||miRNAs||microRNAs||GI cancers||targeted therapy||drug resistance||miR-7||gene expression||cancer cell||prognosis||follicular lymphoma||marginal zone lymphoma||Waldenström’s macroglobulinemia||hairy cell leukemia||primary cutaneous follicle center lymphoma||normal B-cell development||therapeutic target||diagnosis||solid cancer||post-transcriptional regulation||hepatocellular carcinoma||Hippo kinase||Yes-associated protein||liver disease||cancer therapy||PDAC||survival||expression profiling||ovarian cancer||epithelial ovarian cancer||liquid biopsy||circulating miRNAs||drug response||personalized medicine||chemotherapy||n/a
700			_aLovat, Francesca
856			_uhttps://mdpi.com/books/pdfview/book/4936
942			_cEB
999			_c9203 _d9203